Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease

Journal of Clinical Laboratory Analysis

Volumn 28, Issue 3, 2014, Pages 191-197

  Dandana, Azza ^a   Gammoudi, Imen ^a   Chalghoum, Abdelkader ^a   Chahed, Hinda ^a   Addad, Faouzi ^b   Ferchichi, Salima ^a   Miled, Abdelhedi ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Biochemical atherosclerosis markers; Coronary artery disease; Cystatin C; Estimated glomerular filtration rate

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; TRIACYLGLYCEROL; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; METABOLISM; MULTIVARIATE ANALYSIS; STATISTICAL MODEL;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIPOPROTEINS, HDL; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84899658810     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21665     Document Type: Article

References (37)

1. Koc M, Batur MK, Karaarslan O, Abali G. Clinical utility of serum cystatin C in predicting coronary artery disease. Cardiol J 2010;17(4):374-380.
2. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007;116(1):85-97.
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth A. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation, modification of diet in renal disease study. Group Intern Med 1999;130:461-470.
5. Arpegard J, Ostergren J, De Faire U, Hansson LO, Svensson P. Cystatin C-A marker of peripheral atherosclerotic disease? Atherosclerosis 2008;199:397-401.
6. Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Ann Biol Clin 2010;68(5):517-529.
7. Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem 1991;37(5):695-700.
8. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003;18(10): 2024-2031.
9. Laterza OF, Price CP, Scott MG. Cystatin C: An improved estimator of glomerular filtration rate. Clin Chem 2002;48(5):699-707.
10. Luc G, Bard JM, Lesueur C, et al. Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis 2006;185(2):375-380.
11. Niccoli G, Conte M, Della Bona R, et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate. Atherosclerosis 2008;198(2):373-380.
12. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-126.
13. Yagi K. Assay of lipid peroxides in blood plasma or serum. Methods Enzymol 1984;105:328-331.
14. Davis BJ. Disc electrophoresis II, methods and application to human serum proteins. Ann N Y Acad Sci 1964;121:404-427.
15. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51: 606.
16. Turk V, Bode W. The cystatins: Protein inhibitors of cysteine proteinases . FEBS Lett 1991;285:213-219.
17. Coll E, Botey A, lvarez AL, et al. Serum cystatin-C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000;36:29-34.
18. Ix JH, Shlipack MG, Chertow GM, Whooley MA. Association of cystatin-C with mortality, cardiovascular events, and incidente heart failure among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation 2007;115:173-179.
19. van Holten TC, Waanders LF, de Groot PG, et al. Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS One 2013 Apr 22;8(4):e62080. doi: 10.1371/journal.pone.0062080. Print 2013.
20. Zethelius B, Berglund L, Sundström J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358(20):2107-2116.
21. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-1421.
22. Shlipak MG, Katz R, Cushman M, et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 2005;118(12):1416.
23. Wang J, Sim AS, Wang XL, et al. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease. Atherosclerosis 2008;197(2):853-859.
24. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. Clin Chem 2005;51: 321-327.
25. Poggio ED, Wang X, Greene T, Van LF, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005;16:459-466.
26. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002;40:221-226.
27. Leung-Tack J, Tavera C, Gensac MC, Martinez J, Colle A. Modulation of phagocytosis-associated respiratory burst by human cystatin C: Role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg. Exp Cell Res 1990;188:16-22.
28. Font R, Prats M, Gutiérrez C, et al. Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease? Nefrologia 2009;29(3):228-235.
29. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: A systematic review and meta-analysis. Mayo Clin Proc 2008;83:1203-1212.
30. Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 2005;28(4):346-349.
31. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001; 47:2055-2059.
32. Maurer MS, Burkhoff D, Fried LP, Gottdiener J, King DL, Kitzman DW. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: The Cardiovascular Health Study. J Am Coll Cardiol 2007;49:972-981.
33. Naruse H, Ishii J, Kawai T, et al. Cystatin C in acute heart failure without advanced renal impairment. Am J Med 2009;122(6):566-573.
34. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583.
35. Bengtsson E, To F, Hakansson K, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:2151-2156.
36. Oorni K, Sneck M, Bromme D, et al. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro. J Biol Chem 2004;279:34776-34784.
37. Rodgers KJ, Watkins DJ, Miller AL, et al. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006;26:851-856.